Header Logo

Carlos Iribarren

Concepts (529)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Coronary Disease
20
2017
183
3.520
Why?
Coronary Artery Disease
31
2017
134
3.380
Why?
Cardiovascular Diseases
23
2024
599
3.030
Why?
Calcinosis
17
2017
40
2.820
Why?
European Continental Ancestry Group
29
2017
529
2.540
Why?
Asthma
18
2016
387
2.400
Why?
Humans
173
2024
17822
2.250
Why?
Female
149
2024
12780
2.240
Why?
Genome-Wide Association Study
22
2022
249
2.200
Why?
Male
136
2021
10145
2.140
Why?
Polymorphism, Single Nucleotide
33
2022
379
2.120
Why?
Middle Aged
113
2024
8020
2.100
Why?
Risk Factors
79
2024
3362
2.100
Why?
Long QT Syndrome
4
2021
6
2.060
Why?
Breast Diseases
5
2020
18
1.900
Why?
Adult
91
2022
7708
1.780
Why?
Aged
82
2024
6173
1.720
Why?
Pulmonary Disease, Chronic Obstructive
16
2015
197
1.580
Why?
Electrocardiography
7
2021
42
1.550
Why?
Heart Failure
8
2024
396
1.520
Why?
Cohort Studies
50
2021
2590
1.500
Why?
Tobacco Smoke Pollution
9
2010
34
1.480
Why?
Cerebrovascular Disorders
3
2017
34
1.480
Why?
African Americans
16
2017
472
1.400
Why?
California
39
2020
2328
1.390
Why?
Smoking
15
2012
484
1.310
Why?
Electronic Health Records
4
2023
698
1.270
Why?
Omalizumab
3
2017
4
1.120
Why?
Hispanic Americans
8
2017
404
1.100
Why?
Myocardial Infarction
9
2011
238
1.100
Why?
Prospective Studies
35
2024
1286
1.060
Why?
Anti-Asthmatic Agents
2
2017
85
1.050
Why?
Asian Americans
5
2017
176
0.990
Why?
Predictive Value of Tests
15
2017
354
0.920
Why?
Case-Control Studies
28
2021
1120
0.910
Why?
Mammography
4
2017
169
0.900
Why?
Hypersensitivity
2
2017
18
0.890
Why?
Incidence
24
2017
1269
0.870
Why?
Delivery of Health Care, Integrated
5
2021
537
0.860
Why?
Continental Population Groups
5
2017
302
0.860
Why?
Lung Diseases, Interstitial
1
2023
5
0.850
Why?
Kidney Failure, Chronic
7
2011
151
0.830
Why?
Prognosis
14
2022
609
0.830
Why?
Aged, 80 and over
24
2020
1931
0.810
Why?
Arrhythmias, Cardiac
4
2024
32
0.800
Why?
Postmenopause
3
2020
243
0.800
Why?
Algorithms
8
2023
239
0.800
Why?
Breast
3
2017
85
0.790
Why?
Health Status Disparities
2
2017
147
0.790
Why?
Blood Pressure
9
2020
303
0.790
Why?
African Continental Ancestry Group
14
2016
162
0.780
Why?
Hostility
6
2015
7
0.780
Why?
Torsades de Pointes
1
2021
1
0.770
Why?
Myocardial Ischemia
1
2021
24
0.760
Why?
Metabolic Syndrome
5
2016
81
0.760
Why?
Genetic Predisposition to Disease
17
2016
376
0.740
Why?
Phenotype
11
2022
151
0.680
Why?
Cognitive Dysfunction
1
2020
50
0.680
Why?
Tomography, X-Ray Computed
10
2009
211
0.670
Why?
Incidental Findings
3
2009
26
0.660
Why?
Age Factors
17
2016
923
0.650
Why?
Stroke
5
2017
315
0.640
Why?
Hypertrophy, Left Ventricular
2
2017
14
0.640
Why?
Dementia
1
2020
112
0.620
Why?
Quantitative Trait Loci
5
2022
38
0.620
Why?
Lung
3
2023
62
0.610
Why?
Severity of Illness Index
15
2015
455
0.600
Why?
Biomarkers
12
2016
310
0.600
Why?
Proportional Hazards Models
14
2022
711
0.590
Why?
Disability Evaluation
5
2012
46
0.590
Why?
Reproductive History
1
2017
17
0.580
Why?
Risk Assessment
14
2016
1103
0.580
Why?
Databases, Factual
3
2017
315
0.540
Why?
Adolescent
23
2015
3690
0.540
Why?
Health Status
11
2010
299
0.540
Why?
Prevalence
13
2017
888
0.540
Why?
Aging
5
2015
163
0.530
Why?
Environmental Exposure
2
2010
117
0.530
Why?
Health Maintenance Organizations
7
2017
417
0.520
Why?
Troponin I
1
2016
8
0.520
Why?
Genetic Testing
1
2016
72
0.520
Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
3
2011
5
0.500
Why?
Phospholipases A
2
2006
2
0.500
Why?
Breast Neoplasms
4
2024
957
0.490
Why?
Cholesterol
4
2007
106
0.480
Why?
Linear Models
10
2016
232
0.480
Why?
Cross-Sectional Studies
12
2020
1335
0.480
Why?
Hospitalization
12
2020
810
0.470
Why?
Sex Factors
11
2013
644
0.470
Why?
Time Factors
9
2017
1097
0.470
Why?
Follow-Up Studies
19
2016
1219
0.460
Why?
Aortic Diseases
2
2007
2
0.460
Why?
Arginine
3
2010
12
0.450
Why?
Fatty Acids, Omega-3
3
2016
22
0.450
Why?
Occupational Exposure
4
2008
67
0.450
Why?
Surveys and Questionnaires
13
2015
1323
0.440
Why?
Heart
3
2020
13
0.430
Why?
Longitudinal Studies
10
2019
720
0.430
Why?
Carotenoids
3
2010
29
0.420
Why?
Odds Ratio
10
2019
673
0.410
Why?
Heart Diseases
2
2005
77
0.410
Why?
Drug-Related Side Effects and Adverse Reactions
1
2013
107
0.400
Why?
Life Style
4
2017
334
0.400
Why?
Body Mass Index
14
2015
967
0.390
Why?
Genetic Loci
5
2016
55
0.390
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
172
0.390
Why?
Comorbidity
5
2017
597
0.390
Why?
Logistic Models
12
2013
928
0.390
Why?
Respiratory Function Tests
5
2019
32
0.390
Why?
Genome, Human
6
2015
32
0.380
Why?
Radiographic Image Enhancement
2
2009
3
0.380
Why?
Radiographic Image Interpretation, Computer-Assisted
2
2009
7
0.380
Why?
Angiopoietin-1
1
2011
2
0.380
Why?
Angiopoietin-2
1
2011
2
0.380
Why?
Receptor, TIE-2
1
2011
2
0.380
Why?
Vascular Endothelial Growth Factor A
1
2011
3
0.380
Why?
Neovascularization, Physiologic
1
2011
3
0.380
Why?
Health
3
2015
33
0.370
Why?
Genotype
14
2015
227
0.370
Why?
Ischemic Attack, Transient
2
2017
27
0.370
Why?
Hypertension
5
2016
505
0.360
Why?
Multivariate Analysis
11
2013
569
0.360
Why?
Seafood
2
2016
8
0.360
Why?
Postural Balance
2
2008
10
0.360
Why?
Anaphylaxis
1
2010
15
0.350
Why?
Environmental Monitoring
1
2010
26
0.340
Why?
United States
20
2017
4007
0.340
Why?
Body Height
5
2013
62
0.330
Why?
Health Policy
2
2007
123
0.320
Why?
Idiopathic Pulmonary Fibrosis
2
2020
5
0.320
Why?
Social Support
2
2008
207
0.310
Why?
Muscle Strength
5
2012
12
0.310
Why?
Death, Sudden, Cardiac
3
2021
35
0.310
Why?
Heart Rate
3
2013
41
0.310
Why?
Atherosclerosis
3
2020
53
0.310
Why?
Quality of Life
8
2009
511
0.300
Why?
Consumer Behavior
1
2008
29
0.300
Why?
Language
1
2008
53
0.300
Why?
Socioeconomic Factors
8
2012
630
0.300
Why?
Confidence Intervals
5
2012
237
0.300
Why?
Walking
3
2009
86
0.300
Why?
Social Class
2
2008
121
0.300
Why?
Obesity
6
2015
842
0.300
Why?
Acute Coronary Syndrome
1
2008
18
0.290
Why?
Health Education
1
2008
111
0.290
Why?
Workplace
2
2007
30
0.290
Why?
Body Composition
2
2010
90
0.290
Why?
Asymptomatic Diseases
3
2016
29
0.290
Why?
Analysis of Variance
6
2013
159
0.290
Why?
Multiphasic Screening
1
2007
8
0.280
Why?
Angina Pectoris
4
2007
16
0.280
Why?
Fishes
3
2016
10
0.280
Why?
Aortic Aneurysm, Abdominal
1
2007
6
0.280
Why?
Asian Continental Ancestry Group
7
2016
90
0.280
Why?
Neoplasms
3
2006
445
0.280
Why?
Respiration
1
2007
8
0.280
Why?
Motor Activity
4
2011
212
0.280
Why?
Health Behavior
2
2010
360
0.270
Why?
Abdomen
1
2006
20
0.270
Why?
Leptin
1
2006
29
0.270
Why?
Lung Neoplasms
2
2009
260
0.270
Why?
Diabetic Nephropathies
1
2006
26
0.270
Why?
Health Services Accessibility
2
2007
292
0.270
Why?
Lung Diseases, Obstructive
2
2012
11
0.260
Why?
Child
6
2017
2497
0.260
Why?
Endostatins
1
2006
1
0.260
Why?
Depression
4
2009
506
0.260
Why?
Adiposity
1
2006
66
0.260
Why?
Sex Distribution
7
2017
190
0.250
Why?
Computational Biology
2
2015
27
0.250
Why?
Sensitivity and Specificity
4
2017
305
0.240
Why?
Personality
2
2015
9
0.240
Why?
Television
2
2015
22
0.240
Why?
Critical Care
1
2005
71
0.230
Why?
Coronary Vessels
3
2011
15
0.230
Why?
Fatty Acids, Omega-6
1
2004
3
0.220
Why?
Air Pollution, Indoor
1
2004
7
0.220
Why?
Age of Onset
4
2008
79
0.220
Why?
Retrospective Studies
10
2013
2467
0.220
Why?
Molecular Epidemiology
6
2015
44
0.220
Why?
Alcohol Drinking
4
2011
373
0.210
Why?
Anthropometry
2
2013
66
0.210
Why?
Respiratory Tract Diseases
2
2006
25
0.210
Why?
Mental Disorders
2
2010
280
0.210
Why?
Lipids
3
2013
82
0.210
Why?
Cancer Survivors
1
2024
85
0.210
Why?
Survival Analysis
2
2017
216
0.200
Why?
Chromosome Mapping
3
2010
17
0.200
Why?
Genetic Variation
3
2012
81
0.200
Why?
Ventricular Dysfunction, Left
1
2022
20
0.200
Why?
Ethnic Groups
4
2016
485
0.190
Why?
Spirometry
6
2019
65
0.190
Why?
Medication Adherence
1
2024
246
0.190
Why?
Thyroid Neoplasms
1
2001
12
0.190
Why?
Educational Status
4
2011
200
0.190
Why?
Blood Glucose
2
2016
349
0.190
Why?
Alanine Transaminase
1
2001
22
0.180
Why?
Cholesterol, HDL
4
2016
81
0.180
Why?
Waist-Hip Ratio
5
2013
23
0.180
Why?
Diet
3
2024
366
0.180
Why?
Regulatory Sequences, Nucleic Acid
1
2020
2
0.180
Why?
Diabetes Complications
1
2001
114
0.180
Why?
Cholesterol, LDL
4
2016
119
0.180
Why?
Kidney Diseases
3
2011
53
0.180
Why?
Aorta, Thoracic
1
2000
2
0.180
Why?
Peripheral Vascular Diseases
1
2000
4
0.180
Why?
Reproducibility of Results
7
2010
381
0.180
Why?
Risk
5
2014
518
0.170
Why?
Respiratory Distress Syndrome, Adult
1
2000
9
0.170
Why?
Vasodilation
2
2011
8
0.170
Why?
Sex Characteristics
4
2015
69
0.170
Why?
Uric Acid
3
2009
9
0.170
Why?
Pulmonary Emphysema
1
2019
11
0.170
Why?
Forced Expiratory Volume
6
2019
69
0.160
Why?
Health Surveys
3
2010
261
0.160
Why?
Kaplan-Meier Estimate
2
2016
129
0.160
Why?
Suicide, Attempted
1
2000
102
0.160
Why?
Genetic Markers
2
2016
25
0.160
Why?
Central America
2
2009
4
0.160
Why?
Chi-Square Distribution
4
2011
154
0.160
Why?
Mexico
2
2009
19
0.160
Why?
Cross Infection
1
1998
27
0.150
Why?
Cardiovascular Agents
2
2024
24
0.150
Why?
Animals
5
2016
262
0.150
Why?
Triglycerides
3
2013
89
0.150
Why?
Alleles
4
2011
85
0.150
Why?
Oligonucleotide Array Sequence Analysis
3
2015
23
0.150
Why?
Arteries
1
2017
8
0.150
Why?
Blood Coagulation Factors
2
2007
10
0.150
Why?
Intracranial Hemorrhages
1
2017
16
0.150
Why?
Calcium
3
2007
35
0.150
Why?
Delivery of Health Care
1
2021
417
0.150
Why?
Oceanic Ancestry Group
1
2017
33
0.140
Why?
Brain Ischemia
1
2017
37
0.140
Why?
Indians, North American
1
2017
49
0.140
Why?
Treatment Outcome
4
2014
1265
0.140
Why?
Abdominal Fat
2
2007
14
0.140
Why?
Gene Frequency
7
2013
43
0.140
Why?
Placebo Effect
1
2017
7
0.140
Why?
Young Adult
6
2016
2464
0.140
Why?
Tibial Arteries
2
2020
5
0.140
Why?
Population Surveillance
3
2007
264
0.140
Why?
Chromosomes, Human, X
1
2016
2
0.140
Why?
International Classification of Diseases
1
2017
85
0.140
Why?
Protective Factors
1
2016
32
0.140
Why?
Double-Blind Method
1
2017
160
0.140
Why?
Activities of Daily Living
4
2012
85
0.140
Why?
Patient Acceptance of Health Care
1
2020
391
0.130
Why?
Up-Regulation
1
2016
7
0.130
Why?
Contraceptives, Oral
2
2013
26
0.130
Why?
Health Knowledge, Attitudes, Practice
2
2010
382
0.130
Why?
Managed Care Programs
3
2008
325
0.130
Why?
Interviews as Topic
4
2012
305
0.130
Why?
Product Surveillance, Postmarketing
1
2016
95
0.130
Why?
Phospholipases A2
2
2006
2
0.120
Why?
Carotid Artery Diseases
2
2009
13
0.120
Why?
Genotyping Techniques
1
2015
26
0.120
Why?
Urban Population
2
2007
116
0.120
Why?
Telomere
1
2015
19
0.120
Why?
Randomized Controlled Trials as Topic
1
2017
329
0.120
Why?
Overweight
2
2009
270
0.120
Why?
Wounds and Injuries
1
2015
47
0.120
Why?
Genomics
1
2015
55
0.120
Why?
Glomerular Filtration Rate
4
2011
154
0.120
Why?
Membrane Proteins
2
2020
39
0.120
Why?
Metabolic Networks and Pathways
2
2013
6
0.120
Why?
Antibodies, Anti-Idiotypic
1
2014
2
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2014
24
0.110
Why?
Exercise Tolerance
2
2011
13
0.110
Why?
Survival Rate
3
2003
260
0.110
Why?
Risk Adjustment
1
2013
24
0.110
Why?
Cross-Over Studies
1
2013
47
0.110
Why?
Body Weights and Measures
1
2013
12
0.110
Why?
Exercise Test
5
2013
45
0.110
Why?
Insulin
3
2009
213
0.110
Why?
Skin Neoplasms
1
2014
57
0.110
Why?
Body Weight
2
2013
224
0.110
Why?
Meta-Analysis as Topic
4
2016
32
0.100
Why?
Chromatography, High Pressure Liquid
2
2010
10
0.100
Why?
Physical Fitness
2
2012
73
0.100
Why?
Proteins
1
2012
16
0.100
Why?
Health Expenditures
1
2013
76
0.100
Why?
Gonadal Steroid Hormones
1
2012
27
0.100
Why?
Nitroglycerin
2
2011
6
0.100
Why?
DNA Copy Number Variations
1
2012
2
0.100
Why?
Magnetic Resonance Angiography
2
2011
8
0.100
Why?
Vasodilator Agents
2
2011
9
0.100
Why?
Blood Cells
1
2012
4
0.100
Why?
Research Design
3
2009
376
0.100
Why?
Income
2
2013
90
0.100
Why?
Health Services
2
2020
113
0.100
Why?
Angina, Stable
1
2011
4
0.100
Why?
Coronary Circulation
1
2011
4
0.090
Why?
Atrial Fibrillation
1
2013
170
0.090
Why?
High-Throughput Screening Assays
1
2011
4
0.090
Why?
Diabetes Mellitus, Type 2
2
2010
755
0.090
Why?
Brachial Artery
1
2011
6
0.090
Why?
Respiratory Muscles
1
2011
1
0.090
Why?
Ankle Brachial Index
1
2011
8
0.090
Why?
Peripheral Arterial Disease
1
2011
13
0.090
Why?
Lower Extremity
1
2011
13
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
17
0.090
Why?
Self Care
2
2009
163
0.090
Why?
Tryptophan
1
2010
3
0.090
Why?
Kinesin
1
2010
3
0.090
Why?
Muscle, Skeletal
1
2011
34
0.090
Why?
Disabled Persons
2
2012
35
0.090
Why?
Hypoxia
1
2010
8
0.090
Why?
Tunica Media
2
2009
6
0.090
Why?
Chronic Disease
4
2013
428
0.090
Why?
Tunica Intima
2
2009
10
0.090
Why?
Oxygen
1
2010
16
0.090
Why?
Epistasis, Genetic
1
2010
3
0.090
Why?
Genome
1
2010
3
0.090
Why?
Cognition Disorders
1
2010
31
0.090
Why?
Angioedema
1
2010
6
0.090
Why?
Receptors, Nicotinic
1
2010
9
0.090
Why?
Health Care Surveys
2
2008
230
0.090
Why?
Statistics, Nonparametric
3
2010
50
0.090
Why?
Magnetic Resonance Imaging
1
2010
107
0.090
Why?
Epidemiological Monitoring
1
2010
25
0.090
Why?
Coronary Angiography
1
2009
21
0.080
Why?
Diagnosis, Differential
1
2009
60
0.080
Why?
Anxiety Disorders
1
2010
91
0.080
Why?
Promoter Regions, Genetic
2
2008
15
0.080
Why?
Angiography
1
2009
12
0.080
Why?
Nocturia
1
2009
4
0.080
Why?
West Indies
1
2009
1
0.080
Why?
South America
1
2009
4
0.080
Why?
Proteinuria
1
2009
26
0.080
Why?
Emergency Service, Hospital
3
2009
368
0.080
Why?
C-Reactive Protein
2
2008
59
0.080
Why?
Hemoglobins
1
2009
39
0.080
Why?
Multilingualism
1
2008
7
0.080
Why?
Regression Analysis
4
2012
300
0.080
Why?
Reference Values
4
2013
93
0.080
Why?
Epidemiologic Methods
2
2010
81
0.080
Why?
Women's Health
2
2013
202
0.080
Why?
Dust
1
2008
22
0.080
Why?
Inflammation Mediators
1
2008
7
0.080
Why?
Chromosomes, Human, Pair 9
1
2008
7
0.080
Why?
Occupational Diseases
1
2008
41
0.080
Why?
Scavenger Receptors, Class E
1
2008
3
0.080
Why?
Phantoms, Imaging
1
2008
4
0.080
Why?
Arachidonate 5-Lipoxygenase
1
2008
4
0.080
Why?
Insulin Resistance
1
2009
137
0.080
Why?
Carrier Proteins
1
2008
13
0.080
Why?
Interleukin 1 Receptor Antagonist Protein
1
2008
12
0.080
Why?
Mental Health
1
2010
166
0.080
Why?
Age Distribution
3
2017
246
0.070
Why?
Smoking Cessation
2
2007
193
0.070
Why?
Platelet Membrane Glycoproteins
1
2007
3
0.070
Why?
Matrix Metalloproteinase 2
1
2007
3
0.070
Why?
Matrix Metalloproteinase 9
1
2007
4
0.070
Why?
Matrix Metalloproteinases
1
2007
5
0.070
Why?
Fibrin Fibrinogen Degradation Products
1
2007
7
0.070
Why?
Arachidonate 12-Lipoxygenase
1
2007
4
0.070
Why?
Arachidonate 15-Lipoxygenase
1
2007
4
0.070
Why?
Community Networks
1
2008
24
0.070
Why?
Tocopherols
1
2007
5
0.070
Why?
Inflammation
1
2008
64
0.070
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
4
0.070
Why?
Chemokines
1
2007
8
0.070
Why?
Sweden
1
2007
19
0.070
Why?
Calcification, Physiologic
1
2007
1
0.070
Why?
Recurrence
1
2008
189
0.070
Why?
Endothelium, Vascular
1
2007
5
0.070
Why?
Aorta, Abdominal
1
2007
1
0.070
Why?
Infant, Newborn
1
2010
858
0.070
Why?
Risk Management
1
2007
3
0.070
Why?
Early Diagnosis
1
2007
38
0.070
Why?
Electric Impedance
1
2007
7
0.070
Why?
Occupational Health
1
2007
17
0.070
Why?
Carotid Artery, Common
1
2006
2
0.070
Why?
Internal-External Control
1
2006
12
0.070
Why?
Disease Progression
3
2014
267
0.070
Why?
Respiration, Artificial
1
2007
37
0.070
Why?
Internet
1
2008
231
0.070
Why?
Smoking Prevention
1
2007
54
0.070
Why?
Self Concept
1
2006
39
0.070
Why?
San Francisco
2
2008
64
0.070
Why?
Infant
1
2010
1198
0.070
Why?
Employment
1
2006
43
0.070
Why?
Peptic Ulcer
1
2006
14
0.070
Why?
Glucose Intolerance
1
2006
45
0.060
Why?
Allergy and Immunology
1
2005
4
0.060
Why?
Hair
1
2005
7
0.060
Why?
Child, Preschool
1
2010
1424
0.060
Why?
Attitude to Health
1
2007
165
0.060
Why?
Adrenergic beta-Antagonists
1
2006
43
0.060
Why?
Pulmonary Medicine
1
2005
19
0.060
Why?
Mass Screening
1
2011
678
0.060
Why?
Nicotine
1
2005
50
0.060
Why?
Cardiomegaly
1
2005
1
0.060
Why?
Psychometrics
3
2010
121
0.060
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2006
86
0.060
Why?
Polymorphism, Genetic
1
2005
63
0.060
Why?
Models, Theoretical
1
2005
70
0.060
Why?
Time
1
2004
20
0.060
Why?
Registries
1
2006
472
0.060
Why?
Acquired Immunodeficiency Syndrome
1
2005
63
0.060
Why?
Radiography
1
2004
39
0.060
Why?
Internationality
2
2016
14
0.060
Why?
Docosahexaenoic Acids
1
2004
7
0.060
Why?
Principal Component Analysis
2
2015
23
0.050
Why?
Fasting
1
2022
50
0.050
Why?
Glucose
1
2022
32
0.050
Why?
Trastuzumab
1
2022
14
0.050
Why?
Anthracyclines
1
2022
14
0.050
Why?
Ventricular Function, Left
1
2022
51
0.050
Why?
Self Disclosure
1
2001
22
0.050
Why?
Stroke Volume
1
2022
100
0.050
Why?
Africa
2
2011
6
0.050
Why?
Liver
1
2001
33
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2020
8
0.040
Why?
Aorta
1
2020
5
0.040
Why?
Hospitals, Psychiatric
1
2000
3
0.040
Why?
Chromatin
1
2020
5
0.040
Why?
Gene Expression Regulation
1
2020
23
0.040
Why?
Acute-Phase Reaction
1
2000
1
0.040
Why?
Anticholesteremic Agents
1
2000
14
0.040
Why?
Kidney
1
2020
53
0.040
Why?
Glycated Hemoglobin A
1
2001
216
0.040
Why?
Weight Gain
1
2001
173
0.040
Why?
Arteriosclerosis
1
2000
20
0.040
Why?
Antioxidants
1
2000
40
0.040
Why?
Drug Synergism
1
1999
3
0.040
Why?
Respiratory Tract Neoplasms
1
1999
2
0.040
Why?
Head and Neck Neoplasms
1
1999
6
0.040
Why?
Dose-Response Relationship, Drug
1
1999
129
0.040
Why?
Hospital Mortality
1
2000
145
0.040
Why?
Suicide
1
2000
124
0.040
Why?
Linkage Disequilibrium
2
2008
30
0.040
Why?
Ultrasonography
2
2009
36
0.040
Why?
Clinical Coding
1
2017
11
0.040
Why?
Neural Networks (Computer)
1
2017
1
0.030
Why?
Emergency Medical Services
2
2007
48
0.030
Why?
Haplotypes
2
2008
34
0.030
Why?
Outcome Assessment (Health Care)
2
2009
228
0.030
Why?
Microarray Analysis
1
2016
2
0.030
Why?
Exercise
1
2001
495
0.030
Why?
Cells, Cultured
1
2016
12
0.030
Why?
Echocardiography
2
2007
32
0.030
Why?
Walk Test
1
2015
5
0.030
Why?
Leukocytes, Mononuclear
1
2015
9
0.030
Why?
Automation
1
2015
24
0.030
Why?
Quality Control
1
2015
45
0.030
Why?
Pedigree
1
2015
61
0.030
Why?
Risk-Taking
1
2015
109
0.030
Why?
Human Activities
1
2014
1
0.030
Why?
Biological Transport
1
2013
2
0.030
Why?
Models, Economic
1
2013
19
0.030
Why?
Kidney Function Tests
1
2003
22
0.030
Why?
Heart Conduction System
1
2013
4
0.030
Why?
Waist Circumference
1
2013
39
0.030
Why?
Renal Dialysis
1
2003
57
0.030
Why?
Cell Line
1
2012
10
0.030
Why?
Gene Regulatory Networks
1
2012
9
0.030
Why?
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
1
2012
1
0.030
Why?
Co-Repressor Proteins
1
2012
1
0.030
Why?
Repressor Proteins
1
2012
13
0.030
Why?
Progesterone
1
2012
5
0.030
Why?
Nerve Tissue Proteins
1
2012
22
0.030
Why?
Testosterone
1
2012
23
0.030
Why?
Individuality
1
2012
2
0.020
Why?
Myelodysplastic Syndromes
1
2012
2
0.020
Why?
Demography
1
2012
101
0.020
Why?
Twins, Monozygotic
1
2012
12
0.020
Why?
Patient Selection
1
2003
190
0.020
Why?
Menopause
1
2012
69
0.020
Why?
Estrogen Replacement Therapy
1
2012
99
0.020
Why?
Far East
1
2011
6
0.020
Why?
Asia
1
2011
15
0.020
Why?
Europe
1
2011
42
0.020
Why?
Nitric Oxide Donors
1
2011
3
0.020
Why?
Mutation
1
2012
131
0.020
Why?
Ultrasonography, Doppler
1
2011
5
0.020
Why?
Observer Variation
1
2010
37
0.020
Why?
Chromosomes, Human, Pair 3
1
2010
3
0.020
Why?
Pilot Projects
1
2011
219
0.020
Why?
Multifactorial Inheritance
1
2010
20
0.020
Why?
Body Size
1
2010
31
0.020
Why?
Adipose Tissue
1
2010
64
0.020
Why?
Models, Genetic
1
2010
23
0.020
Why?
Computer Simulation
1
2010
82
0.020
Why?
Emigration and Immigration
1
2009
15
0.020
Why?
Helplessness, Learned
1
2009
1
0.020
Why?
Cystatin C
1
2009
15
0.020
Why?
Psychiatric Status Rating Scales
1
2010
125
0.020
Why?
Statistics as Topic
1
2010
64
0.020
Why?
Korea
1
2009
9
0.020
Why?
Oxygen Consumption
1
2009
10
0.020
Why?
Cluster Analysis
1
2009
90
0.020
Why?
Models, Statistical
1
2010
178
0.020
Why?
Creatinine
1
2009
65
0.020
Why?
Propensity Score
1
2009
85
0.020
Why?
Anxiety
1
2009
151
0.020
Why?
5-Lipoxygenase-Activating Proteins
1
2008
4
0.020
Why?
Lung Volume Measurements
1
2008
2
0.020
Why?
Image Interpretation, Computer-Assisted
1
2008
12
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2007
3
0.020
Why?
Fibrinogen
1
2007
13
0.020
Why?
Cell Line, Tumor
1
2007
8
0.020
Why?
Disease Susceptibility
1
2007
37
0.020
Why?
Mutagenesis
1
2007
5
0.020
Why?
Mice, Knockout
1
2007
16
0.020
Why?
Kidney Neoplasms
1
2007
16
0.020
Why?
Tissue Plasminogen Activator
1
2007
23
0.020
Why?
Protein Array Analysis
1
2007
5
0.020
Why?
Confounding Factors (Epidemiology)
1
2007
86
0.020
Why?
Area Under Curve
1
2007
34
0.020
Why?
Mice
1
2007
69
0.020
Why?
Psychology
1
2006
16
0.020
Why?
Absenteeism
1
2006
24
0.020
Why?
Energy Metabolism
1
2006
51
0.020
Why?
ROC Curve
1
2006
77
0.020
Why?
Leisure Activities
1
2006
31
0.020
Why?
Utilization Review
1
2005
53
0.020
Why?
Base Sequence
1
2005
19
0.020
Why?
Heart Atria
1
2005
3
0.020
Why?
Intensive Care Units
1
2005
105
0.010
Why?
Cotinine
1
2001
7
0.010
Why?
Chicago
1
2001
26
0.010
Why?
Alabama
1
2001
23
0.010
Why?
Minnesota
1
2001
53
0.010
Why?
Causality
1
2001
40
0.010
Why?
Urban Health
1
2001
38
0.010
Why?
Bilirubin
1
2000
30
0.010
Why?
Vitamins
1
2000
64
0.010
Why?
Concepts (529)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente